Net Cash Provided by (Used in) Financing Activities of FibroBiologics, Inc. from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
FibroBiologics, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • FibroBiologics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $3,278,000, a 77% decline year-over-year.
  • FibroBiologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $16,907,000, a 23% increase from 2023.
  • FibroBiologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $13,793,000, a 133% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

FibroBiologics, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $16,907,000 +$3,114,000 +23% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $13,793,000 +$7,868,000 +133% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $5,925,000 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY

FibroBiologics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $3,278,000 -$11,288,000 -77% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $14,566,000 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.